Andrew Hollander

The TP53-ARF tumor suppressor pathway is frequently disrupted in large/cell anaplastic medulloblastoma

Adrian Frank, Roberto Hernán, Andrew Hollander et al. · Molecular Brain Research · 2004 · 68 citations

Veterinary Medicine, Molecular Genetics, Oncology +14

Mutational analysis of PDGFR–RAS/MAPK pathway activation in childhood medulloblastoma

Richard J. Gilbertson, Jaqueline A. Langdon, Andrew Hollander et al. · European Journal of Cancer · 2006 · 44 citations

Medicine, Genetics, Oncology +16

An Integrated Method for Reproducible and Accurate Image-Guided Stereotactic Cranial Irradiation of Brain Tumors Using the Small Animal Radiation Research Platform

Brian C. Baumann, Joseph L. Benci, Phillip P. Santoiemma et al. · Translational Oncology · 2012 · 38 citations · Full text

Medicine, Oncology, Radiation Oncology +17

Intracranial control after Cyberknife radiosurgery to the resection bed for large brain metastases

Jennifer Vogel, Eric Ojerholm, Andrew Hollander et al. · Radiation Oncology · 2015 · 23 citations · Full text

Medicine, Oncology, Surgery +16

A unified multi‐activation (UMA) model of cell survival curves over the entire dose range for calculating equivalent doses in stereotactic body radiation therapy (SBRT), high dose rate brachytherapy (HDRB), and stereotactic radiosurgery (SRS)

Shidong Li, Curtis Miyamoto, Bin Wang et al. · Medical Physics · 2021 · 12 citations · Full text

Medicine, Oncology, Radiation Oncology +17